Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 711 of 1,261
  1. US 9249099

    Crystalline forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  2. US 9248190

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  3. US 9248179

    Pan-lyssavirus vaccines against rabies

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  4. US 9248161

    Method for therapeutic replenishment and enrichment of ocular surface lubrication

    The Regents of the University of California · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  5. US 9248175

    Live-attenuated compositions for bacterial infections

    Northwestern University · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  6. US 9248147

    Methods for endoscopic mucosal resection and endoscopic submucosal dissection

    The Board of Regents of the University of Texas System · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  7. US 9248145

    Two alkylresorcinol synthase genes from sorghum; cloning, expression, transformation and characterization

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  8. US 9248131

    Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  9. US 9248132

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  10. US 9248113

    Infusion and injection solution of Levodopa

    Dizlin Medical Design AB · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  11. US 9247910

    Artificial tissue systems and uses thereof

    UNIVERSITY OF CONNECTICUT · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  12. EP 2976360

    THERAPIE MIT ANTIKÖRPERN GEGEN CLAUDIN 18.2 ZUR BEHANDLUNG VON KREBS

    GANYMED PHARMACEUTICALS AG [DE] · Granted Jan 27, 2016 · Expires Jan 22, 2036

    granted
  13. US 9241928

    Antimicrobial compounds

    Northwestern University · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  14. US 9241934

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  15. US 9243055

    HERV-K antigens, antibodies, and methods

    The Board of Regents of the University of Texas System · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  16. US 9241982

    Purified plasmodium and vaccine compositions

    Sanaria Inc. · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  17. US 9242937

    Pharmaceutically active disubstituted pyridine derivatives

    Lead Discovery Center GmbH · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  18. US 9243281

    Neuroprotective chemicals and methods for identifying and using same

    The Board of Regents of the University of Texas System · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  19. US 9242000

    Micro-RNAs and micro-RNA inhibitors to modulate blood vessel growth, patterning, tumor growth and malignant disease and method for making and using them

    The Regents of the University of California · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  20. US 9241998

    Methods and compositions for treatment of cancer using oncolytic RSV activity

    The Board of Regents of the University of Texas System · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  21. US 9241999

    Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system

    The Board of Regents of the University of Texas System · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  22. US 9243239

    Purification of cystathionine beta-synthase

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  23. US 9241976

    Use of HDL-related molecules to treat and prevent proinflammatory conditions

    The Regents of the University of California · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  24. US 9241910

    Orally-disintegrating solid preparation

    Takeda Pharmaceutical Company Limited · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.